The U.S. Defense Health Agency awarded a $5,386,587 Project Grant (CFDA 12.420 - Military Medical Research and Development) to Cerulean Scientific Inc. on June 1, 2024. This grant supports the development of an "Omniphobic Cerebral Shunt to Eliminate Clogging and Dysfunction". Cerulean Scientific Inc., a small disadvantaged business manufacturer, will use the funding to conduct research and development on creating and optimizing tethered liquid perfluorocarbon (TLP) coatings for medical devices. Specific objectives include developing TLP coatings for hemodialysis catheters, urinary catheters, and extracorporeal membrane oxygenation device membranes to improve performance and reduce complications like infections and thrombosis. The grant will enable Cerulean Scientific to carry out optimization studies, biocompatibility and efficacy testing, regulatory filings, and manufacturing scale-up for these enhanced medical device coatings.
Generated 3/4/25, 7:24 AM